Newsroom / COVID-19

In some territories, which are listed in our website footer, our microsampling devices are supplied for therapeutic or IVD use as referenced in some of our content. Outside of those territories our devices are supplied for research use only (RUO).

by Neoteryx, on September 23,2021

September 2021 — According to a preprint article slated for publication in the next issue of the journal Bioanalysis, the COVID-19 pandemic led to a shift in the way blood …

Read Story

by Neoteryx, on June 24,2021

June 2021 — According to a research article published online in the June 22, 2021 issue of Science Translational Medicine, data from a sero-surveillance study analyzing blood samples gathered from participants …

Read Story

by Neoteryx, on April 22,2021

At the end of March 2021, Quanterix Corporation issued a press release announcing that its Simoa® technology had been used in a research study to detect the SARS-CoV-2 virus. According …

Read Story

by Neoteryx, on March 17,2021

AUCKLAND, NEW ZEALAND – March 2021 – New Zealand has proved to be one of the most successful nations in responding effectively to the coronavirus pandemic and controlling the spread …

Read Story

by Neoteryx, on July 18,2020

According to a July 15, 2020 announcement posted on NewsWise, Vysnova Partners Inc., Wake Forest Baptist Health, and several other health organizations have received a $54-million contract from the US …

Read Story

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news